How do recent RxPonder results affect your adjuvant therapy choice for premenopausal women with HR+/HER2 negative breast cancer with 1-3 positive LNs?   

Would you consider an Oncotype or Mammaprint? Would your management change if the patient had 1-3 positive LNs on SLNBx (as opposed to ALND)?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Gerard J Ventura MD, FACP
At least for premenopausal patients, the data seem...
Medical Oncologist
What is the interpretation of LN micro metastasis ...
Sign in or Register to read more